Postherpetic neuralgia-associated secretory protein biomarkers related to major depressive disorder: an integrated bioinformatics, clinical, and experimental study
Background Postherpetic neuralgia (PHN) is a debilitating neuropathic pain disorder that is frequently accompanied by depressive symptoms. Increasing evidence suggests that immune dysregulation contributes to depression. However, the molecular mechanisms linking PHN and major depressive disorder (MDD) remain poorly understood. This study aimed to identify PHN-associated secretory protein biomarkers potentially involved in MDD and to evaluate their biological and clinical relevance. Methods A PHN whole-blood RNA sequencing (RNA-seq) dataset (PRJNA1142765) and three blood-derived major depressive disorder (MDD) datasets (GSE76826, GSE32280, and GSE39653) were analyzed. PHN-associated secretory protein genes were identified through differential expression analysis and integration with a curated secretory protein gene set, whereas MDD-related genes were identified using weighted gene co-expression network analysis (WGCNA). Protein-protein interaction network analysis, functional enrichment analysis, and machine-learning algorithms were applied to identify hub genes and construct a diagnostic nomogram. The identified biomarkers were subsequently validated in an independent clinical cohort and an HSV-1-induced PHN-like mouse model. Results A total of 133 PHN-associated secretory protein genes and 702 MDD-related module genes were identified. Integration analyses and machine-learning approaches identified four hub genes, namely LTF, HLA-DPA1, CACNA2D4, and CD40LG. Functional enrichment analyses indicated significant involvement of immune-regulatory pathways and cell adhesion-related processes. A four-gene signature showed good discrimination in the training cohort (AUC = 0.839, 95% CI: 0.728 - 0.949) and moderate discrimination in the independent GSE39653 cohort (AUC = 0.738, 95% CI: 0.593 - 0.883). Clinical and experimental validation further supported the biological relevance of the identified biomarkers. Moreover, modulation of CD40LG and LTF improved pain hypersensitivity and depressive-like behaviors in the PHN-like mouse model. Conclusions This study identified four PHN-associated secretory protein-related biomarkers (LTF, HLA-DPA1, CACNA2D4, and CD40LG) that may participate in immune-regulatory mechanisms associated with MDD. These findings provide candidate biomarkers and hypothesis-generating targets for future mechanistic and translational investigations of PHN-associated depressive symptoms.
Authors
- Zhuohui Ning
- Huang Ming
- Wei Pan (ORCID: https://orcid.org/0000-0002-8938-6880)
- Xiang Xiao (ORCID: https://orcid.org/0000-0002-9714-9543)
- Zeyang Zhu
- Shiyan Liao
Institutions
- Sun Yat-sen University (CN)
- Shanxi Medical University (CN)
- The Seventh Affiliated Hospital of Sun Yat-sen University (CN)
- Foshan Maternity and Child Health Care Hospital (CN)
- First Hospital of Shanxi Medical University (CN)
- Southern Medical University Shenzhen Hospital (CN)
- Southern Medical University (CN)
- South China University of Technology (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3389/fimmu.2026.1920147
- Primary Topic
- Pain Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00